Labshake search
Citations for Bio X Cell :
1 - 17 of 17 citations for Somatostatin Tumor Inhibiting Analog since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2022Quote: ... Tumors were treated with anti-PD-1 purchased from BioxCell InVivoMAb anti-mouse PD-1 (catalog #BE0146) ...
-
bioRxiv - Immunology 2023Quote: ... Tumor-bearing mice were treated with anti-CTLA-4 (BioXCell) (n=8 ...
-
bioRxiv - Cancer Biology 2021Quote: For checkpoint blockade treatment optimization on mc38 tumors anti-PD1 (RMP1-14, Bioxcell), anti-PD1 (mPD1-4H2-mIgG1-D265A ...
-
bioRxiv - Immunology 2020Quote: Tumor and draining lymph node samples were blocked with anti-mouse CD16/32 antibodies (BioXCell) for 20 min at 4 °C and stained with surface antibodies (Supplementary Table 1 ...
-
bioRxiv - Immunology 2019Quote: ... 4T1 tumor-bearing mice were injected intraperitoneally with 250 μg anti-PD1 (InVivoPlus RMP1-14, BioXCell) and/or 100μg anti-CTLA4 antibodies (InVivoPlus 9H10 ...
-
bioRxiv - Immunology 2022Quote: ... or were completely clear of tumors: anti-CD8-α for CD8+ T cells (clone 2.43, BioXCell), anti-CD4 for CD4+ T cells (clone GK1.5 ...
-
bioRxiv - Immunology 2023Quote: ... or were completely clear of tumors: anti-CD8-α for CD8+ T cells (clone 2.43, BioXCell), anti-CD4 for CD4+ T cells (clone GK1.5 ...
-
bioRxiv - Cancer Biology 2020Quote: ... tumor-bearing mice were intraperitoneally injected (8-10mg/kg) with either an IgG2a isotype control antibody (BioXCell #BE0089), or an anti-PD-1 antibody (BioXCell #BE0146 ...
-
bioRxiv - Immunology 2021Quote: ... B16-OVA tumor bearing mice were treated with 200 µg of anti-CD8α monoclonal antibody (clone 53-6.7, BioXcell) or 200 µg of anti-NK1.1 monoclonal antibody (clone PK136 ...
-
bioRxiv - Cell Biology 2020Quote: ... mice bearing ~50mm3 tumors were randomized and treated with 200 μg of anti-PD-1 antibody (BioXcell, Clone RMP1-14) or isotype control via IP injections three times weekly for 4 doses ...
-
bioRxiv - Immunology 2023Quote: ... tumor-bearing mice were injected intraperitoneally with 100 μg of anti-CTLA-4 (clone UC10-4F10-11, Bio X Cell) and 100 μg of anti-PD-L1 (clone 10F.9G2 ...
-
bioRxiv - Cancer Biology 2023Quote: ... we injected mice (i.p.) bearing MC38 tumors with 200 μg mouse IgG1 isotype control (clone MOPC-21; BioXCell; Cat #EB0083) or 200 μg mouse αIFNAR1 antibody (clone MAR1-5A3 ...
-
bioRxiv - Cancer Biology 2024Quote: Tumor-bearing mice were injected intraperitoneally every four days with either cocktail of anti-PD1 (250 μg/dose, #BE0146, BioXcell) and anti-CTLA4 (100 μg/dose ...
-
bioRxiv - Neuroscience 2024Quote: ... MMTV-PyMT +/- female mice at 7 weeks after the tumor onset were intravenously injected with the anti-PD-L1 antibody (BioXcell, #BE0101 ...
-
bioRxiv - Cancer Biology 2020Quote: ... were used for checkpoint blocking on tumors as well as T cells: functional grade PD-L1 (29E.2A3) and CTLA-4 (BN13) (Bioxcell, USA). In brief ...
-
bioRxiv - Cancer Biology 2022Quote: ... and 13 after orthotopic tumor implantatio n mice were intraperitoneally injected with 200 μg of anti-PD-L1 monoclonal antibody (RMP1-14, BioXCell, BE0146, Lot: 810421D1) or isotype control (IgG2a ...
-
bioRxiv - Cancer Biology 2021Quote: ... C26 tumor-bearing mice received intraperitoneal injections with InVivoMAb anti-mouse IL-6 (1 mg in 200μl PBS; Bio X Cell, clone MP5-20F3). Body weight ...